**Core Concept**
The most sensitive screening test for congenital malformations in diabetic mothers is crucial for early detection and management of fetal anomalies.

**Why the Correct Answer is Right**
The correct answer is **A. Ultrasonography**. This is because ultrasonography allows for detailed visualization of fetal anatomy, enabling the detection of congenital malformations such as cardiac defects, neural tube defects, and limb abnormalities. The use of high-resolution ultrasound and skilled operators has improved the sensitivity of this test. Additionally, the detection of fetal anomalies via ultrasonography can lead to timely intervention and improved fetal outcomes.

**Why Each Wrong Option is Incorrect**
**Option B:** **Maternal serum alpha-fetoprotein (MSAFP)** is a screening test for neural tube defects, but it is not as sensitive as ultrasonography for detecting a wide range of congenital malformations.
**Option C:** **Non-stress test (NST)** is a screening test for fetal well-being, but it does not provide information about congenital malformations.
**Option D:** **Biophysical profile (BPP)** is a comprehensive assessment of fetal well-being, but it is not primarily used for detecting congenital malformations.

**Clinical Pearl / High-Yield Fact**
Ultrasonography should be performed at 18-22 weeks of gestation to optimize the detection of congenital malformations in diabetic mothers.

**Correct Answer: A. Ultrasonography**